These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1169 related items for PubMed ID: 16409817
1. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X, Lin JF. Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817 [Abstract] [Full Text] [Related]
2. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF, Li X, Zhu MW. Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 07; 41(10):684-8. PubMed ID: 17199924 [Abstract] [Full Text] [Related]
3. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A. Eur J Obstet Gynecol Reprod Biol; 2014 Sep 07; 180():56-60. PubMed ID: 25020276 [Abstract] [Full Text] [Related]
4. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS). Lin XF, Wu RR, Du J, Liao YC, Du Y, Ye Y, Wang Y, Zhang XB, Wu C, Chen A. Clin Exp Obstet Gynecol; 2015 Sep 07; 42(3):315-20. PubMed ID: 26152001 [Abstract] [Full Text] [Related]
5. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J. Gynecol Endocrinol; 2010 Oct 07; 26(10):736-42. PubMed ID: 20569105 [Abstract] [Full Text] [Related]
6. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women. Sanke S, Chander R, Jain A, Garg T, Yadav P. JAMA Dermatol; 2016 Sep 01; 152(9):986-91. PubMed ID: 27304785 [Abstract] [Full Text] [Related]
7. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J, Bergh T, Gennarelli G, Wide L. Clin Endocrinol (Oxf); 1994 Oct 01; 41(4):473-81. PubMed ID: 7955458 [Abstract] [Full Text] [Related]
8. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z. Neuro Endocrinol Lett; 2007 Dec 01; 28(6):807-10. PubMed ID: 18063948 [Abstract] [Full Text] [Related]
9. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S, Akhtar N, Ahmad J. Diabetes Metab Syndr; 2012 Dec 01; 6(4):207-11. PubMed ID: 23199540 [Abstract] [Full Text] [Related]
10. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Hum Reprod; 2008 Jul 01; 23(7):1602-6. PubMed ID: 18378560 [Abstract] [Full Text] [Related]
11. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. Li L, Chen X, He Z, Zhao X, Huang L, Yang D. J Pediatr Adolesc Gynecol; 2012 Dec 01; 25(6):390-5. PubMed ID: 23089573 [Abstract] [Full Text] [Related]
12. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women. El-Eshmawy MM, Ibrahim A, Bahriz R, Shams-Eldin N, Mahsoub N. BMC Endocr Disord; 2022 Dec 13; 22(1):315. PubMed ID: 36514085 [Abstract] [Full Text] [Related]
13. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome]. Li Y, Wei LN, Xiong YL, Liang XY. Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 13; 45(8):567-70. PubMed ID: 21029609 [Abstract] [Full Text] [Related]
14. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA, Shin SY, Yoon BK, Choi D. Gynecol Endocrinol; 2007 Aug 13; 23(8):461-7. PubMed ID: 17852414 [Abstract] [Full Text] [Related]
15. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F. Gynecol Endocrinol; 2014 Nov 13; 30(11):781-4. PubMed ID: 25137507 [Abstract] [Full Text] [Related]
16. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome]. Wang Y, Mao WW, Chen YJ, Li MZ, Qiao J, Wang LN. Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 13; 42(11):756-60. PubMed ID: 18307903 [Abstract] [Full Text] [Related]
17. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J. Gynecol Endocrinol; 2016 Nov 13; 32(1):38-41. PubMed ID: 26291816 [Abstract] [Full Text] [Related]
18. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease]. Chen Y, Wang XJ, Jin HL, Jin L. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun 13; 33(6):751-6. PubMed ID: 23980352 [Abstract] [Full Text] [Related]
19. Serum HLA-G levels in women with polycystic ovary syndrome. Oztekin O, Fenkci SM, Fenkci V, Enli Y, Cabus U. Gynecol Endocrinol; 2015 Mar 13; 31(3):243-6. PubMed ID: 25403326 [Abstract] [Full Text] [Related]
20. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H. Gynecol Endocrinol; 2005 May 13; 20(5):258-63. PubMed ID: 16019370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]